1. Anti-thrombotic effect of a heparin-like substance (SP 54) preventing red cell and platelet aggregation;Bicher;Arzneim.-Forsch.,1970
2. Antithrombotic activity of glycosaminoglycans of mammalian origin;Niada,1979
3. In vivo evaluation of the antithrombotic effects of some polysaccharides of ultra low molecular weight;Fareed;Thromb. Haemostasis (Abst.),1981
4. A comparative study of heparin and heparin fractions in preventing experimental venous thrombosis;Thomas;Thromb. Haemostasis (Abst.),1981
5. A novel anti-thrombotic heparinoid (Org 10172) devoid of bleeding inducing capacity: A survey of its pharmacological properties in experimental animal models;Meuleman;Thromb. Res.,1982